With more than one billion people worldwide now obese, it is calling for more widespread and fairer access to GLP-1 medication.
According to projections, more than two billion will be obese by 2030 unless action is taken.
High costs, limited production capacity, and supply-chain constraints are major barriers to universal access to the injections that can help people shift significant weight, says WHO.
It has already added them to its „essential“ medicines list that countries are advised to provide.
WHO director-general Tedros Adhanom Ghebreyesus said: „Our new guidance recognises that obesity is a chronic disease that can be treated with comprehensive and lifelong care.
„While medication alone won’t solve this global health crisis, GLP-1 therapies can help millions overcome obesity and reduce its associated harms.“
WHO says these drugs, sometime called skinny jabs, represent a new chapter in the gradual conceptual shift in how society approaches obesity, from a „lifestyle condition“ to a complex, preventable, and treatable chronic disease.
It says the drugs can be taken long-term – for six months or more – but must be prescribed along with advice on diet and exercise, so that people can keep the weight off.
Too few people around the world can access them, says WHO. „Our greatest concern is equitable access,“ said Tedros.
Skinny jab shortage
Even under the current best projected scenario, the production of GLP-1 therapies could only cover around 100 million people – less than 10% of those who need them, according to the WHO.
The guideline calls on countries and companies to expand access, through strategies such as voluntary licensing – where a pharmaceutical company grants permission for others to make affordable non-brand versions of its patented drug.
A patent on semaglutide – the core ingredient of Novo Nordisk’s Wegovy – is due to expire in several countries in 2026, meaning other drug-makers will soon be free to produce and sell cheap versions in places like India, Canada, China, Brazil and Turkey.
WHO says countries must also create healthier environments to promote good health and prevent obesity.
How obesity jabs work
GLP-1 drugs mimick a natural hormone to slow digestion, curb appetite and increase feelings of fullness so people eat less.
In the UK, the injections are prescription only medicines, which means they can only be prescribed by a healthcare professional for a person who clinically needs it.
Some are available on the NHS, but more are sold privately.
There is a black market and to be safe people should avoid buying from unregulated sellers such as beauty salons or via social media.
People typically start to lose weight within a few weeks of starting on the weekly injections.
Research suggests people may put most of the weight back on within a year of stopping the medication though, as their normal food cravings return.
Being overweight or obese increases your risk for developing health problems, such as diabetes, heart disease, stroke, and certain cancers.
mclannee on
I believe obesity will be remembered as a 21st century problem, the economic benefits of not having to treat obese people far outweigh the costs of these medications.
It’s a no brainer for public health services to provide this drug to obese individuals along.
scrotalsmoothie on
Waiting for some numbnut politician to suggest putting it into public water.
Mostest_Importantest on
Just rewrite society and social constructs to prioritize socializing and actively living, instead of sitting in boxes while trillionaires count yachts.
Easy.
Or, we could just….well…steady on ahead, lads.
bucketofardvarks on
If we’re globally in this position because foods have been made hyperpalatable, is taking it just a short term fix before uber-hyper-mega palatable food is designed that people on GLP-1s will overeat as well and gain weight again?
I’ve struggled with the last 10kg after losing 30kg myself slowly over a few years, I’d take that over being tied to a monthly fee to be thin any day but I do realise GLP1s are making weight loss more achievable and overall, that’s a net positive for healthcare providers although I have no info on if people on GLP1s also start exercising more for cardiovascular health (on average) etc
BroForceOne on
I thought the warning would have been over shortage of food but okay.
Dead_Eye_Donny on
Could just try eating less and exercising more instead of taking medication that has unknown long term side effects but that doesn’t bring in billions of profit for big pharma
DeanoPreston on
The good news is several companies are developing their own version, there’s several in clinical trials now.
edfitz83 on
Yo momma is so fat…. That kind of jab?
FOTY2015 on
Typical WHO, fear-shilling drugs for obesity rather than promoting healthy life style.
Responsible_Set8856 on
The reputation of the BBC isn’t good.
ExogamousUnfolding on
WHO used the word „jab“ ??? because I instantly think an idiot wrote this headline.
CykoPathe on
What happened to the ‚Big is Beautiful‘ movement?
BeelzeBat on
I’m sure there will be no long-time consequences from injecting diabetes medicine into non-diabetic people 👍
Zifrian on
It’s not obesity medicine- it’s designed to lower your sugar and A1C. The weight loss is a side effect.
What-The_What on
Many prescription drug plans are dropping coverage for GLP-1 drugs in 2026, so I imagine demand will drop quite a bit once people have to pay retail prices.
keke-WinnieBean on
They need to prescribe for folks with prediabetes! Been climbing up the prediabetes number line for two years – with diet and exercise in check and within normal limits for BMi, it’s in the genes – and I’ve been told I will have to actually get diabetes to be able to obtain a prescription covered by insurance.
seamuwasadog on
Disappointing for me. I was prescribed one for, you know, diabetes. It’s not just more convenient than pills, it’s the first that doesn’t cause me unpleasant and/or dangerous side effects with a good level of blood sugar control. I’d hate to have to go back.
Jaded-Entrepreneur36 on
Calling them obesity jabs is so fucking lame. This shit has done nothing for my weight but helped lower my a1c , and control my blood sugars .
VegasKL on
These „obesity jabs“ seem like they’re treating the symptoms and not addressing the disease. And don’t get me wrong, it’s great they’re able to address that.
Governments need to do a better job tackling the root causes of the West getting fatter — educate, stricter labeling standards (without industry forcing confusing compromises), and start figuring out how to force companies to not load everything with sugar.
Yrths on
These things aren’t even available in my country, and we are much more obese than the US. How much of the world even has access; have they not always been in ’shortage‘?
It’s odd for such a hard to get medicine to already be on the essential medicines list.
Negative-Date-9518 on
Hollywood in absolute shambles at the thought
imjustkeepinitreal on
Once a mass produced cheaper version comes out that would be great
ANALyzeThis69420 on
Just take Lizzo.
Atenti87 on
Novonordisk:”Ok, I will be the most valuable country in Europe again”
brainarid on
Dey took er jAAAbs!!!
omnigear on
I’m waiting for the holy grail one , no muscle mass loss, upkeep metabolism,
ogrizzled on
„Obesity Jab“ is just a softened version of Trump’s preferred term „fat shot“.
OneComposer4239 on
These comments are literal gold.
Space-manSpiff23 on
No shortage of prescriptions for Lizzo
Leave A Reply
Du musst angemeldet sein, um einen Kommentar abzugeben.
30 Kommentare
With more than one billion people worldwide now obese, it is calling for more widespread and fairer access to GLP-1 medication.
According to projections, more than two billion will be obese by 2030 unless action is taken.
High costs, limited production capacity, and supply-chain constraints are major barriers to universal access to the injections that can help people shift significant weight, says WHO.
It has already added them to its „essential“ medicines list that countries are advised to provide.
WHO director-general Tedros Adhanom Ghebreyesus said: „Our new guidance recognises that obesity is a chronic disease that can be treated with comprehensive and lifelong care.
„While medication alone won’t solve this global health crisis, GLP-1 therapies can help millions overcome obesity and reduce its associated harms.“
WHO says these drugs, sometime called skinny jabs, represent a new chapter in the gradual conceptual shift in how society approaches obesity, from a „lifestyle condition“ to a complex, preventable, and treatable chronic disease.
It says the drugs can be taken long-term – for six months or more – but must be prescribed along with advice on diet and exercise, so that people can keep the weight off.
Too few people around the world can access them, says WHO. „Our greatest concern is equitable access,“ said Tedros.
Skinny jab shortage
Even under the current best projected scenario, the production of GLP-1 therapies could only cover around 100 million people – less than 10% of those who need them, according to the WHO.
The guideline calls on countries and companies to expand access, through strategies such as voluntary licensing – where a pharmaceutical company grants permission for others to make affordable non-brand versions of its patented drug.
A patent on semaglutide – the core ingredient of Novo Nordisk’s Wegovy – is due to expire in several countries in 2026, meaning other drug-makers will soon be free to produce and sell cheap versions in places like India, Canada, China, Brazil and Turkey.
WHO says countries must also create healthier environments to promote good health and prevent obesity.
How obesity jabs work
GLP-1 drugs mimick a natural hormone to slow digestion, curb appetite and increase feelings of fullness so people eat less.
In the UK, the injections are prescription only medicines, which means they can only be prescribed by a healthcare professional for a person who clinically needs it.
Some are available on the NHS, but more are sold privately.
There is a black market and to be safe people should avoid buying from unregulated sellers such as beauty salons or via social media.
People typically start to lose weight within a few weeks of starting on the weekly injections.
Research suggests people may put most of the weight back on within a year of stopping the medication though, as their normal food cravings return.
Being overweight or obese increases your risk for developing health problems, such as diabetes, heart disease, stroke, and certain cancers.
I believe obesity will be remembered as a 21st century problem, the economic benefits of not having to treat obese people far outweigh the costs of these medications.
It’s a no brainer for public health services to provide this drug to obese individuals along.
Waiting for some numbnut politician to suggest putting it into public water.
Just rewrite society and social constructs to prioritize socializing and actively living, instead of sitting in boxes while trillionaires count yachts.
Easy.
Or, we could just….well…steady on ahead, lads.
If we’re globally in this position because foods have been made hyperpalatable, is taking it just a short term fix before uber-hyper-mega palatable food is designed that people on GLP-1s will overeat as well and gain weight again?
I’ve struggled with the last 10kg after losing 30kg myself slowly over a few years, I’d take that over being tied to a monthly fee to be thin any day but I do realise GLP1s are making weight loss more achievable and overall, that’s a net positive for healthcare providers although I have no info on if people on GLP1s also start exercising more for cardiovascular health (on average) etc
I thought the warning would have been over shortage of food but okay.
Could just try eating less and exercising more instead of taking medication that has unknown long term side effects but that doesn’t bring in billions of profit for big pharma
The good news is several companies are developing their own version, there’s several in clinical trials now.
Yo momma is so fat…. That kind of jab?
Typical WHO, fear-shilling drugs for obesity rather than promoting healthy life style.
The reputation of the BBC isn’t good.
WHO used the word „jab“ ??? because I instantly think an idiot wrote this headline.
What happened to the ‚Big is Beautiful‘ movement?
I’m sure there will be no long-time consequences from injecting diabetes medicine into non-diabetic people 👍
It’s not obesity medicine- it’s designed to lower your sugar and A1C. The weight loss is a side effect.
Many prescription drug plans are dropping coverage for GLP-1 drugs in 2026, so I imagine demand will drop quite a bit once people have to pay retail prices.
They need to prescribe for folks with prediabetes! Been climbing up the prediabetes number line for two years – with diet and exercise in check and within normal limits for BMi, it’s in the genes – and I’ve been told I will have to actually get diabetes to be able to obtain a prescription covered by insurance.
Disappointing for me. I was prescribed one for, you know, diabetes. It’s not just more convenient than pills, it’s the first that doesn’t cause me unpleasant and/or dangerous side effects with a good level of blood sugar control. I’d hate to have to go back.
Calling them obesity jabs is so fucking lame. This shit has done nothing for my weight but helped lower my a1c , and control my blood sugars .
These „obesity jabs“ seem like they’re treating the symptoms and not addressing the disease. And don’t get me wrong, it’s great they’re able to address that.
Governments need to do a better job tackling the root causes of the West getting fatter — educate, stricter labeling standards (without industry forcing confusing compromises), and start figuring out how to force companies to not load everything with sugar.
These things aren’t even available in my country, and we are much more obese than the US. How much of the world even has access; have they not always been in ’shortage‘?
It’s odd for such a hard to get medicine to already be on the essential medicines list.
Hollywood in absolute shambles at the thought
Once a mass produced cheaper version comes out that would be great
Just take Lizzo.
Novonordisk:”Ok, I will be the most valuable country in Europe again”
Dey took er jAAAbs!!!
I’m waiting for the holy grail one , no muscle mass loss, upkeep metabolism,
„Obesity Jab“ is just a softened version of Trump’s preferred term „fat shot“.
These comments are literal gold.
No shortage of prescriptions for Lizzo